Spots Global Cancer Trial Database for enzalutamide 40 mg
Every month we try and update this database with for enzalutamide 40 mg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage | NCT05627752 | Prostate Cancer Castrate Resist... | Enzalutamide 40... Docetaxel injec... | 18 Years - 75 Years | Zhongnan Hospital | |
Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study | NCT03464201 | Ovarian Cancer | Enzalutamide 40... | 18 Years - | Grupo Español de Tumores Huérfanos e Infrecuentes | |
Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study | NCT03464201 | Ovarian Cancer | Enzalutamide 40... | 18 Years - | Grupo Español de Tumores Huérfanos e Infrecuentes |